Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland.
J Infect Dis. 2019 Jul 2;220(3):346-349. doi: 10.1093/infdis/jiz133.
A converging public health crisis is emerging because the opioid epidemic is fueling a surge in infectious diseases, such as human immunodeficiency virus infection with or without AIDS, the viral hepatitides, infective endocarditis, and skin and soft-tissue infections. An integrated strategy is needed to tailor preventive and therapeutic approaches toward infectious diseases in people who misuse and/or are addicted to opioids and to concurrently address the underlying predisposing factor for the infections-opioid use disorder. This commentary highlights the unique and complementary roles that the infectious diseases and substance use disorder communities can play in addressing this crisis of dual public health concerns.
一个集中的公共卫生危机正在出现，因为阿片类药物泛滥正在推动传染病的激增，如艾滋病毒感染伴或不伴艾滋病、病毒性肝炎、感染性心内膜炎以及皮肤和软组织感染。需要采取综合战略，针对滥用和/或成瘾阿片类药物的人群制定传染病的预防和治疗方法，并同时解决导致感染的根本促成因素——阿片类药物使用障碍。本评论强调了传染病和物质使用障碍社区在应对这双重公共卫生关注危机方面可以发挥的独特和互补作用。
